BioPharma Credit Plc (BPCP) ORD USD0.01(GBP)

Sell:70.00pBuy:71.40p2.70p (3.97%)

Prices delayed by at least 15 minutes
Sell:70.00p
Buy:71.40p
Change:2.70p (3.97%)
Prices delayed by at least 15 minutes
Sell:70.00p
Buy:71.40p
Change:2.70p (3.97%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
30 October 2024
Harry Abraham HymanChairman of the Board
Buy
Regular purchase transaction
151£0.67£100.54109,289
31 July 2024
Harry Abraham HymanChairman of the Board
Buy
Regular purchase transaction
65£0.71£45.91109,138
30 April 2024
Harry Abraham HymanChairman of the Board
Buy
Regular purchase transaction
67£0.70£47.06109,073
27 March 2024
Sapna Hasmukhrai ShahNon-Executive Director
Buy
Regular purchase transaction
20,000£0.72£14,302.0082,542
15 March 2024
Harry Abraham HymanChairman of the Board
Buy
Regular purchase transaction
109£0.69£75.44109,006
5 January 2024
Harry Abraham HymanChairman of the Board
Buy
Regular purchase transaction
126£0.72£91.31108,897

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
27 March 2024
Sapna Hasmukhrai ShahNon-Executive Director
Buy
Regular purchase transaction
20,000£0.72£14,302.0082,542
30 October 2024
Harry Abraham HymanChairman of the Board
Buy
Regular purchase transaction
151£0.67£100.54109,289
5 January 2024
Harry Abraham HymanChairman of the Board
Buy
Regular purchase transaction
126£0.72£91.31108,897
15 March 2024
Harry Abraham HymanChairman of the Board
Buy
Regular purchase transaction
109£0.69£75.44109,006
30 April 2024
Harry Abraham HymanChairman of the Board
Buy
Regular purchase transaction
67£0.70£47.06109,073

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.